SCHEMBL454556

SCHEMBL454556

[c]1ccc2cccc3c2c1-c1ccc2ccccc2c1-3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.41
ANPEP P15144 1/20 0.39
ALDH1A1 P00352 9/20 0.38
HSD17B10 Q99714 7/20 0.38
HPGD P15428 6/20 0.38
CYP1A2 P05177 5/20 0.38
THRB P10828 1/20 0.38
MAPT P10636 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 5/20 0.35
MAPK1 P28482 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
CES1 P23141 1/20 0.35
CYP2A6 P11509 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NQO2 P16083 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454555 0.87 DNMT1 (0.45) DNMT1ANPEPALDH1A1HSD17B10HPGD
SCHEMBL18221935 0.81 ALDH1A1 (0.42) DNMT1ALDH1A1HSD17B10HPGDCYP1A2
Benzo(J)Fluoranthene SCHEMBL69111 0.77 ALDH1A1 (0.56) DNMT1ANPEPALDH1A1HSD17B10HPGD
SCHEMBL26787 0.77 ALDH1A1 (0.56) DNMT1ALDH1A1HSD17B10HPGDCYP1A2
SCHEMBL17063473 0.76 DNMT1 (0.40) DNMT1ANPEPALDH1A1HSD17B10HPGD
Benzo(J)Fluoranthene SCHEMBL28871006 0.75 ALDH1A1 (0.54) DNMT1ANPEPALDH1A1HSD17B10HPGD
SCHEMBL4916319 0.75 ENPP1 (0.35) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL4912279 0.74 ALDH1A1 (0.41) ANPEPALDH1A1HSD17B10HPGDMAPT
SCHEMBL578393 0.73 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDCYP1A2MAPT
SCHEMBL14718854 0.73 ALDH1A1 (0.40) DNMT1ALDH1A1HSD17B10HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180186902-A1 CATALYSTS QATAR FOUNDATION (QA) 2018-07-05 US claimed
EP-3334769-A1 CATALYSTS Qatar Foundation (QA) 2018-06-20 EP claimed
WO-2017025701-A1 CATALYSTS QATAR FOUNDATION (QA) 2017-02-16 WO claimed
US-20240155945-A1 HIGHLY EFFICIENT BLUE FLUORESCENT ORGANIC EMITTER HAVING A HIGH HOMO LEVEL AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2024-05-09 US disclosed
EP-4349934-A1 A HIGHLY EFFICIENT BLUE FLUORESCENT ORGANIC EMITTER HAVING A HIGH HOMO LEVEL AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME Idemitsu Kosan Co., Ltd (JP) 2024-04-10 EP disclosed
US-11706981-B2 Organic light emitting device and compounds for use in same IDEMITSU KOSAN CO., LTD. (JP) 2023-07-18 US disclosed
US-20230209849-A1 ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING A LIGHT EMITTING LAYER COM-PRISING THREE DIFFERENT COMPOUNDS AND AN ELECTRONIC EQUIPMENT COMPRISING SAID ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2023-06-29 US disclosed
EP-4199130-A1 AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING A LIGHT EMITTING LAYER COMPRISING THREE DIFFERENT COMPOUNDS AND AN ELECTRONIC EQUIPMENT COMPRISING SAID ORGANIC ELECTROLUMINESCENCE DEVICE Idemitsu Kosan Co.,Ltd. (JP) 2023-06-21 EP disclosed
US-20230120308-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-20 US disclosed
US-20230123170-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-20 US disclosed
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-30 US disclosed
US-20110262482-A1 ANTI-VIRAL COMPOUNDS Kineta, Inc. (US) 2011-10-27 US disclosed
WO-2011133722-A2 ANTI-VIRAL COMPOUNDS Kineta, Inc. (US) 2011-10-27 WO disclosed
WO-2011133712-A2 ANTI-VIRAL COMPOUNDS Kineta, Inc. (US) 2011-10-27 WO disclosed
WO-2011119748-A1 COMPOSITIONS COMPRISING A PROSAMIDE FOR TREATING HAIR LOSS, HAIR THINNING, HAIR COLOR LOSS ALLERGAN, INC. (US) 2011-09-29 WO disclosed
WO-2011097553-A1 PYRIDAZINE DERIVATIVES USEFUL AS CANNABINOID - 2 AGONISTS ALLERGAN, INC. (US) 2011-08-11 WO disclosed
US-20110111031-A1 Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof ALLERGAN, INC. 2011-05-12 US disclosed
US-20110052695-A1 DRUG DELIVERY PLATFORMS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF ALLERGAN, INC. (US) 2011-03-03 US disclosed
EP-2197060-A2 Organic light-emitting device Canon Kabushiki Kaisha (JP) 2010-06-16 EP disclosed
US-20100140604-A1 ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230120308-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND ODC1, OR10J3, PIEZO1 DNMT1 75/4885ANPEP 3125/4885ALDH1A1 98/4885
US-20110262482-A1 ANTI-VIRAL COMPOUNDS MAVS, EIF2AK2, IRF3 DNMT1 2449/4885ANPEP 3481/4885ALDH1A1 3477/4885
US-11706981-B2 Organic light emitting device and compounds for use in same SLCO4C1, XPO6, ERCC1 DNMT1 2196/4885ANPEP 3335/4885ALDH1A1 499/4885
US-20110052695-A1 DRUG DELIVERY PLATFORMS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF ILK, MSN, BPHL DNMT1 4684/4885ANPEP 2775/4885ALDH1A1 3862/4885
US-20230123170-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND L1CAM, LEF1, CCNL2 DNMT1 583/4885ANPEP 3741/4885ALDH1A1 292/4885
US-20110111031-A1 Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof ILK, MSN, BPHL DNMT1 4684/4885ANPEP 2775/4885ALDH1A1 3862/4885
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND SLCO4C1, SLCO1A2, PORCN DNMT1 67/4885ANPEP 4068/4885ALDH1A1 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.